Research by the Oral Health CRC (and its predecessor) has resulted in 12 patent families.
Patent title |
Description |
| Antigenic complex for the diagnosis and treatment of P.gingivalis infection | Relevant to development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Stablised calcium phosphate complexes | Improvement to the CPP-ACP complex |
| Dental mineralisation | Improvement to the CPP-ACP complex |
| Ionic complexes | Improvement to the CPP-ACP complex |
| Fluoride composition and methods for dental mineralisation | Improvement to the CPP-ACP complex |
| Treponema denticola polypeptides useful in the prevention of periodontal disease | Identification of the site specific predictors of periodontal disease useful in the development of a chair-side diagnostic |
| Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Immunology treatment for biofilms | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Biofilm treatment | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Prevention, treatment and diagnosis of P.gingivalis infection | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Tanerella forsythia | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Periodontal disease treatment | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Antibiofilm glycopeptides | Relevant to the treatment or prevention of oral conditions including dental caries, gingivitis, periodontitis and oral mucositis |
| Protease inhibitory peptides | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Treatment or prevention of infection | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Gingipain inhibitory propeptides | Relates to compounds, peptides or peptidomimetics that inhibit, reduce or prevent protease activity and the use of these compounds, peptides or peptidomimetics to treat or prevent a condition. |
The program will feature opportunities and challenges, ethical and social aspects of accessing health information over the internet, access and engagement, and examples of..
Read moreProfessor Eric Reynolds AO, CEO of the Oral Health CRC, has been appointed a Melbourne Laureate Professor. This honour, rarely bestowed, is reserved for the most distingui..
Read moreProfessor Mike Morgan, from the Oral Health CRC, has been appointed to the Board of the Victorian Health Promotion Foundation (VicHealth). VicHealth works in partnership ..
Read more